Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer-Reference-Cited by-同舟云学术

Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer

Published:2020-02-06 Issue:3 Volume:31 Page:923-932
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Lee Ruda¹^ORCID,Choi Yu Jin²,Jeong Myeong Seon²,Park Yong Il³,Motoyama Keiichi⁴,Kim Min Woo¹,Kwon Seung-Hae⁵,Choi Jung Hoon⁶^ORCID

Affiliation:

1. International Research Organization for Advanced Science and Technology (IROAST), Kumamoto University, Kumamoto 860-8555, Japan

2. Korea Basic Science Institute, Chuncheon 24341, Republic of Korea

3. School of Chemical Engineering, Chonnam National University, Gwangju 61186, Republic of Korea

4. Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 860-8555, Japan

5. Korea Basic Science Institute, Seoul 02841, Republic of Korea

6. Department of Anatomy & Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University, Chuncheon 24341, Republic of Korea

Funder

Kumamoto University

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.0c00048

Reference48 articles.

1. Cancer statistics, 2011

2. Cancer statistics, 2018

3. Lung Cancer

4. Risk of Recurrence of Resected Stage I Non-small Cell Lung Cancer in Elderly Patients as Compared with Younger Patients

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective Strategies in Designing Chitosan-hyaluronic Acid Nanocarriers: From Synthesis to Drug Delivery Towards Chemotherapy;Current Drug Delivery;2025-01

2. Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles;International Journal of Pharmaceutics: X;2024-12

3. Advances, limitations and perspectives in the use of celecoxib-loaded nanocarriers in therapeutics of cancer;Discover Nano;2024-09-06

4. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09

5. Exploration of Nanomedicine-Based Dry Powder Inhalation Formulation Co-Loaded with Erlotinib and Curcumin for Treatment of Non-Small Cell Lung Cancer;Nano LIFE;2024-07-31